Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aditxt, Inc. - Common Stock (NQ: ADTX )

0.0568 -0.0032 (-5.33%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 83,647,164
Open 0.0543
Bid (Size) 0.0329 (1,803)
Ask (Size) 0.0330 (100)
Prev. Close 0.0600
Today's Range 0.0531 - 0.0580
52wk Range 0.0427 - 218.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's going on in today's after hours session
Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga

Performance

YTD
-70.87%
-70.87%
1 Month
-45.70%
-45.70%
3 Month
-84.05%
-84.05%
6 Month
-99.71%
-99.71%
1 Year
-99.96%
-99.96%

More News

Read More
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-250 Reverse Stock Split Effective at the Open of Trading on March 17, 2025
From Aditxt, Inc.
Via Business Wire
Bulls Turn to Pennies STSS, ADTX, CSDX, SPRC, CBDW, YGTFF During Market Uncertainty – Small-Cap Stocks Poised for Big Moves
Via AB Newswire
Topics Intellectual Property
Exposures Intellectual Property
Is the Market Bullish or Bearish on Aditxt?
Via Benzinga
Curious about the most active stocks on Thursday?
Via Chartmill
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Advances ADI-100 Autoimmune Therapy Toward Clinical Trials
Via Investor Brand Network
Exposures Product Safety
Aditxt Subsidiary Adimune to Ship Drug Substances for Final Drug Product Formulation of ADI-100 Ahead of Planned Clinical Trials in Type 1 Diabetes and Psoriasis in Germany, and Stiff Person Syndrome at the Mayo Clinic in the U.S.
From Aditxt, Inc.
Via Business Wire
These stocks are making the most noise in today's session.
Via Chartmill
Check out the stocks that are attracting the most attention and driving market activity.
Via Chartmill
Check out the stocks that are attracting the most attention and driving market activity.
Via Chartmill
These stocks are making the most noise in today's session.
Via Chartmill
Top 5 Biotech Stocks That Saw Biggest Retail Following Jump Last Week
Via Stocktwits
These stocks are the most active in today's session
Via Chartmill
BioMedNewsBreaks — Aditxt Inc. (NASDAQ: ADTX) Subsidiary Pearsanta Engages Lead Underwriter for Planned IPO
Via Investor Brand Network
Topics Initial Public Offering
Exposures Securities Market
Aditxt Subsidiary Pearsanta Engages Dominari Securities for its Initial Public Offering, to Drive U.S. and Global Commercial Launch of Early Cancer Detection and Diagnosis Targeted for H2 2025
From Aditxt, Inc.
Via Business Wire
Microcap Biotech Aditxt Rallies Retail Interest Ahead Of CEO’s Fireside Chat: What’s On Investors’ Radar?
Via Stocktwits
Topics Initial Public Offering
Exposures Securities Market
Thursday's session: most active stocks
Via Chartmill
The trading volume of these stocks is deviating from the norm in today's session.
Via Chartmill
Which stocks are moving after the closing bell on Wednesday?
Via Chartmill
Discover the most active stocks in Wednesday's session.
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
Why Global Blue Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Get insights into the top gainers and losers of Tuesday's after-hours session.
Via Chartmill
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Via Chartmill
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.